Cancer patients are susceptible to severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2). Different antitumor treatments have attracted wide attention in the context of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has devastated
the world with coronavirus disease 2019 (COVID-19), which has imparted a toll of at least …

We conducted a phase 3 clinical trial to compare the efficacy of platinum-based combination
chemotherapy together with nivolumab plus ipilimumab relative to that of platinum-based …

Cytokine release syndrome (CRS) can be induced by immune checkpoint inhibitors (ICIs).
Although the incidence of CRS is low, it is often underreported. Here, we report two severe …

Cytokine release syndrome (CRS) is a systemic inflammatory syndrome that causes fatal
circulatory failure due to hypercytokinemia, and subsequent immune cell hyperactivation …

Immune checkpoint inhibitors (ICIs) are widely used to treat a variety of cancers and
common infectious diseases with high efficacy. During the coronavirus disease 2019 …

Objective: Unusual clinical course Background: CRS (cytokine release syndrome) is a
massive activation of the inflammatory system characterized by a supra-physiological rate of …

Combination therapy with ipilimumab and nivolumab is indicated for many types of cancers;
however, several patients experience immune-related adverse events (irAEs). We herein …